cAMP protects neutrophils against TNF-α-induced apoptosis by activation of cAMP-dependent protein kinase, independently of exchange protein directly activated by cAMP (Epac)

Journal of Leukocyte Biology

Volumn 76, Issue 3, 2004, Pages 641-647

  Krakstad, Camilla ^a   Christensen, Anne Elisabeth ^a   Døskeland, Stein Ove ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Apoptosis; Cytokine; Inflammation

Indexed keywords

8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ANTIPORTER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANTIGENS, CD; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; FORSKOLIN; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INFLAMMATION; NEUTROPHILS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4344588424     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0104005     Document Type: Article

References (40)

1. Ward, I., Dransfield, I., Chilvers, E. R., Haslett, I., Rossi, A. G. (1999) Pharmacological manipulation of granulocyte apoptosis: potential therapeutic targets. Trends Pharmacol. Sci. 20, 503-509.
2. Simon, H. U., (2003) Neutrophil apoptosis pathways and their modifications in inflammation, Immunol. Rev. 193, 101-110.
3. Heasman, S. J., Giles, K. M., Ward, C., Rossi, A. G., Haslett, C., Dransfield, I. (2003) Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J. Endocrinol. 178, 29-36.
4. Akgul, C., Moulding, D. A., Edwards, S. W. (2001) Molecular control of neutrophil apoptosis. FEBS Lett. 487, 318-322.
5. Walker, R. I., Willemze, R. (1980) Neutrophil kinetics and the regulation of granulopoiesis. Rev. Infect. Dis. 2, 282-292.
6. Parvathenani, L. K., Buescher, E. S., Chacon-Cruz, E., Beebe, S. J. (1998) Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils at a site upstream of caspase-3. J. Biol. Chem. 273, 6736-6743.
7. Kasahara, Y., Iwai, K., Yachie, A., Ohta, K., Konno, A., Seki, H., Miyawaki, T., Taniguchi, N. (1997) Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89, 1748-1753.
8. Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., Loetscher, H. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87, 3127-3131.
9. Renshaw, S. A., Parmar, J. S., Singleton, V., Rowe, S. J., Dockrell, D. H., Dower, S. K., Bingle, C. D., Chilvers, E. R., Whyte, M. K. (2003) Acceleration of human neutrophil apoptosis by TRAIL. J. Immunol. 170, 1027-1033.
10. Colotta, F., Re, F., Polentarutti, N., Sozzani, S., Mantovani, A. (1992) Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood 80, 2012-2020.
11. Lee, A., Whyte, M. K., Haslett, C. (1993) Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J. Leukoc. Biol. 54, 283-288.
12. Rossi, A. G., Cousin, J. M., Dransfield, I., Lawson, M. F., Chilvers, E. R., Haslett, C. (1995) Agents that elevate cAMP inhibit human neutrophil apoptosis. Biochem. Biophys. Res. Commun. 217, 892-899.
13. Niwa, M., Hara, A., Kanamori, Y., Matsuno, H., Kozawa, O., Yoshimi, N., Mori, H., Uematsu, T. (1999) Inhibition of tumor necrosis factor-α induced neutrophil apoptosis by cyclic AMP: involvement of caspase cascade. Eur. J. Pharmacol, 371, 59-67.
14. Ottonello, L., Morone, M. P., Dapino, P., Dallegri, F. (1995) Tumour necrosis factor α-induced oxidative burst in neutrophils adherent to fibronectin: effects of cyclic AMP-elevating agents. Br. J. Haematol. 91, 566-570.
15. Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., Greenberg, M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
16. Gardner, A. M., Johnson, G. L. (1996) Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 271, 14560-14566.
17. Yang, K. Y., Arcaroli, J., Kupfner, J., Pitts, T. M., Park, J. S., Strasshiem, D., Perng, R. P., Abraham, E. (2003) Involvement of phosphatidylinositol 3-kinase γ in neutrophil apoptosis. Cell. Signal. 15, 225-233.
18. Savill, J., Fadok, V. (2000) Corpse clearance defines the meaning of cell death. Nature 407, 784-788.
19. Kopperud, R., Krakstad, C., Selheim, F., Doskeland, S. O. (2003) cAMP effector mechanisms. Novel twists for an 'old' signaling system. FEBS Lett. 546, 121-126.
20. de Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A., Bos, J. L. (1998) Epac is a Rapl guaninenucleotide- exchange factor directly activated by cyclic AMP. Nature 396, 474-477.
21. Francis, S. H., Corbin, J. D. (1999) Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit. Rev. Clin. Lab. Sci. 36, 275-328.
22. Martin, M. C., Dransfield, I., Haslett, C., Rossi, A. G. (2001) Cyclic AMP regulation of neutrophil apoptosis occurs via a novel protein kinase A-independent signaling pathway. J. Biol. Chem. 276, 45041-45050.
23. Christensen, A. E., Selheim, F., De Rooij, J., Dremier, S., Schwede, F., Dao, K. K., Martinez, A., Maenhaut, C., Bos, J. L., Genieser, H. G., Doskeland, S. O. (2003) cAMP analog mapping of Epacl and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J. Biol. Chem. 278, 35394-35402.
24. Enserink, J. M., Christensen, A. E., De Rooij, J., Van Triest, M., Schwede, F., Genieser, H. G., Doskeland, S. O., Blank, J. L., Bos, J. L. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rapl and ERK. Nat. Cell Biol. 4, 901-906.
25. Gjertsen, B. T., Mellgren, G., Otten, A., Maronde, E., Genieser, H. G., Jastorff, B., Vintermyr, O. K., McKnight, G. S., Doskeland, S. O. (1995) Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 β action. J. Biol. Chem. 270, 20599-20607.
26. Rehmann, H., Schwede, F., Doskeland, S. O., Wittinghofer, A., Bos, J. L. (2003) Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac. J. Biol. Chem. 278, 38548-38556.
27. Chijiwa, T., Mishima, A., Hagiwara, M., Sano, M., Hayashi, K., Inoue, T., Naito, K., Toshioka, T., Hidaka, H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(pbromocinnamylamino) ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 5267-5272.
28. Christensen, A. E., Doskeland, S. O. (2003) Cyclic nucleotide analogs. In Handbook of Cell Signaling, Chapter 212, San Diego, CA, Academic/ Elsevier Science, 549-554.
29. Doskeland, S. O., Maronde, E., Gjertsen, B. T. (1993) The genetic subtypes of cAMP-dependent protein kinase-functionally different or redundant? Biochim. Biophys. Acta 1178, 249-258.
30. Francis, S. H., Corbin, J. D. (1994) Structure and function of cyclic nucleotide-dependent protein kinases. Annu. Rev. Physiol. 56, 237-272.
31. Kruppa, J., Keely, S., Schwede, F., Schultz, C., Barrett, K., Jastorff, B. (1997) Bioactivatable derivatives of 8-substituted cAMP-analogues. Bioorg. Med. Chem. Lett. 7, 945-948.
32. Dremier, S., Pohl, V., Poteet-Smith, C., Roger, P. P., Corbin, J., Doskeland, S. O., Dumont, J. E., Maenhaut, C. (1997) Activation of cyclic AMP-dependent kinase is required but may not be sufficient to mimic cyclic AMP-dependent DNA synthesis and thyroglobulin expression in dog thyroid cells. Mol. Cell. Biol. 17, 6717-6726.
33. Kang, G., Joseph, J. W., Chepurny, O. G., Monaco, M., Wheeler, M. B., Bos, J. L., Schwede, F., Genieser, H. G., Holz, G. G. (2003) Epac-selective cAMP analog 8-pCPT-2'-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic β-cells. J. Biol. Chem. 278, 8279-8285.
34. Rangarajan, S., Enserink, J. M., Kuiperij, H. B., de Rooij, J., Price, L. S., Schwede, F., Bos, J. L. (2003) Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rapl upon stimulation of the β 2-adrenergic receptor. J. Cell Biol. 160, 487-493.
35. Lee, I., Bender, E., Kadenbach, B. (2002) Control of mitochondrial membrane potential and ROS formation by reversible phosphorylation of cytochrome c oxidase. Mol. Cell. Biochem. 234-235, 63-70.
36. Yusta, B., Estall, J., Drucker, D. J. (2002) Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 277, 24896-24906.
37. Harada, H., Becknell, B., Wilm, M., Mann, M., Huang, L. J., Taylor, S. S., Scott, J. D., Korsmeyer, S. J. (1999) Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. Mol. Cell 3, 413-422.
38. Gottlieb, E., Vander Heiden, M. G., Thompson, C. B. (2000) Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor α-induced apoptosis. Mol. Cell. Biol. 20, 5680-5689.
39. Dremier, S., Kopperud, R., Doskeland, S. O., Dumont, J. E., Maenhaut, C. (2003) Search for new cyclic AMP-binding proteins. FEBS Lett. 546, 103-107.
40. Pongracz, J., Webb, P., Wang, K., Deacon, E., Lunn, O. J., Lord, J. M. (1999) Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-δ. J. Biol. Chem. 274, 37329-37334.